Saturday, Apr 20, 2024 | Last Update : 07:30 AM IST
drug controller general of india (dcgi)
Cadila Healthcare gets DCGI nod to conduct phase 3 trials for two-dose COVID vaccine
The company has got the permission for conduct of phase III trials for two-dose Covid vaccine, Cadila Healthcare said in a regulatory filing
05 Oct 2021 5:22 PM
LifeCell gets DCGI nod for clinical trial of cell therapy to treat COVID patients
The company has set up a manufacturing facility at its Chennai campus that will further bolster its biologics manufacturing capabilities
16 Sep 2021 3:15 PM
Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial
The drug will be launched under the brand name Desrem in India and will be available to patients later this month
07 Jul 2020 1:48 PM
Hetero gets DCGI nod to launch Remdesivir for COVID-19 treatment
The drug will be available in 100 mg vial which will be administered intravenously in a hospital under healthcare practitioner supervision
21 Jun 2020 2:45 PM
India's Glenmark to conduct trials for potential Covid19 drug
Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%
30 Apr 2020 12:28 PM
India will import drugs with less than 60 pc shelf life, condition apply
Health ministry has instructed to take various steps to ensure availability of a sufficient quantity of drugs in the domestic retail market
19 Apr 2020 11:20 AM
1 of 1
Columns
Baba Ramdev's Apology: Too Little, Too Late for His Alleged Frauds
Preserving Literature or Perpetuating Censorship? The Debate Over Revisionism in Academic Circles
Economic woes, agrarian discontent, and regional dynamics may pose hurdles for BJP's electoral prospects.
The Middle East conflict is complex, with Iran and Israel adopting strategies to neutralize each other